The Lancet. Rheumatology e506 e498 Investigators, ISARICC & Dark, P 2021, ' Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort: a matched, prospective cohort study. ', The Lancet. Rheumatology, vol. 3, no. 7, pp. e498-e506 . https://doi.org/10.1016/S2665-9913(21)00104-1 2021, ' Non-steroidal anti-inflammatory drug use and outcomes of COVID-19 in the ISARIC Clinical Characterisation Protocol UK cohort : a matched, prospective cohort study ', The Lancet Rheumatology, vol. 3, no. 7, pp. e498-e506 . https://doi.org/10.1016/S2665-9913(21)00104-1, https://doi.org/10.1016/S2665-9913(21)00104-1 The Lancet Rheumatology
Gupta, RK, Harrison, EM, Ho, A, Docherty, AB, Knight, SR, van, S M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, TM, Investigators, ISARICC & Dark, P 2021, ' Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19: a prospective cohort study. ', The Lancet. Respiratory medicine . https://doi.org/10.1016/s2213-2600(20)30559-2 The Lancet. Respiratory Medicine The Lancet Respiratory Medicine Gupta, R K, Harrison, E M, Ho, A, Docherty, A B, Knight, S R, van Smeden, M, Abubakar, I, Lipman, M, Quartagno, M, Pius, R, Buchan, I, Carson, G, Drake, T M, Dunning, J, Fairfield, C J, Gamble, C, Green, C A, Halpin, S, Hardwick, H E, Holden, K A, Horby, P W, Jackson, C, Mclean, K A, Merson, L, Nguyen-Van-Tam, J S, Norman, L, Olliaro, P L, Pritchard, M G, Russell, C D, Scott-Brown, J, Shaw, C A, Sheikh, A, Solomon, T, Sudlow, C, Swann, O V, Turtle, L, Openshaw, P J M, Baillie, J K, Semple, M G, Noursadeghi, M & The ISARIC4C Investigators, 2021, ' Development and validation of the ISARIC 4C Deterioration model for adults hospitalised with COVID-19 : a prospective cohort study ', The Lancet Respiratory Medicine . https://doi.org/10.1016/S2213-2600(20)30559-2
RECOVERY Collaborative Group & Downey, D 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 LANCET Mumford, A, Ramanan, A V & Gibbison, B J J & Welch, H F 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5, https://doi.org/10.1016/S0140-6736(21)00149-5 The Lancet RECOVERY Collaborative Group, Felton, T, Evans, D G, Murray, C, Buch, M & Dark, P 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial ', Lancet (London, England), vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5 2021, ' Azithromycin in patients admitted to hospital with COVID-19 (RECOVERY) : a randomised, controlled, open-label, platform trial ', Lancet, vol. 397, no. 10274, pp. 605-612 . https://doi.org/10.1016/S0140-6736(21)00149-5
75.e11 Cell COG-UK Consortium, Robson, S C, Beckett, A, Loveson, K F, Chauhan, A J, Glaysher, S, Elliott, S, Bourgeois, Y, Scarlett, G P, Brooks, T T, Williams, T & Parker, M D 2021, ' Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity ', Cell, vol. 184, no. 1, pp. 64-75 . https://doi.org/10.1016/j.cell.2020.11.020 BMJ Volz, E M, Hill, V, McCrone, J T, Price, A, Jorgensen, D, O'Toole, Á, Southgate, J, Johnson, R, Jackson, B, Nascimento, F F, Rey, S M, Nicholls, S M, Colquhoun, R M, Filipe, A D S, Shepherd, J, Pascall, D J, Shah, R, Jesudason, N, Li, K, Jarrett, R F, Pacchiarini, N, Bull, M, Geidelberg, L, Siveroni, I, Goodfellow, I, Loman, N J, Pybus, O G, Robertson, D L, Thomson, E C, Rambaut, A & Connor, T R 2020, ' Evaluating the effects of SARS-CoV-2 spike mutation D614G on transmissibility and pathogenicity ', Cell, vol. 184, no. 1, pp. 64-75.E11 . https://doi.org/10.1016/j.cell.2020.11.020
2020, ' Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease : An International Multicenter Study ', American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 12, pp. 1656-1665 . https://doi.org/10.1164/rccm.202007-2794OC Dipòsit Digital de Documents de la UAB Universitat Autònoma de Barcelona Drake, T M, Docherty, A B, Harrison, E M, Quint, J K, Adamali, H, Agnew, S, Babu, S, Barber, C M, Barratt, S, Bendstrup, E, Bianchi, S, Villegas, D C, Chaudhuri, N, Chua, F, Coker, R, Chang, W, Crawshaw, A, Crowley, L E, Dosanjh, D, Fiddler, C A, Forrest, I A, George, P M, Gibbons, M A, Groom, K, Haney, S, Hart, S P, Heiden, E, Henry, M, Ho, L P, Hoyles, R K, Hutchinson, J, Hurley, K, Jones, M, Jones, S, Kokosi, M, Kreuter, M, MacKay, L S, Mahendran, S, Margaritopoulos, G, Molina-Molina, M, Molyneaux, P L, O'Brien, A, O'Reilly, K, Packham, A, Parfrey, H, Poletti, V, Porter, J C, Renzoni, E, Rivera-Ortega, P & ISARIC4C Investigators 2020, ' Outcome of hospitalization for COVID-19 in patients with interstitial lung disease an international multicenter study ', American Journal of Respiratory and Critical Care Medicine, vol. 202, no. 12, pp. 1656-1665 . https://doi.org/10.1164/rccm.202007-2794OC Drake, TM, Docherty, AB, Harrison, EM, Quint, JK, Adamali, H, Agnew, S, Babu, S, Barber, CM, Barratt, S, Bendstrup, E, Bianchi, S, Castillo, V D, Investigators, ISARICC & Dark, P 2020, ' Outcome of Hospitalization for COVID-19 in Patients with Interstitial Lung Disease. An International Multicenter Study. ', American Journal of Respiratory and Critical Care Medicine . https://doi.org/10.1164/rccm.202007-2794oc, https://doi.org/10.1164/rccm.202007-2794oc American Journal of Respiratory and Critical Care Medicine